US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2659 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
PR953, Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR954
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
BRC961, Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR/ER/PR/Her-2(neu) IHC results, 48 cases/96 cores
KD2084, Renal disease spectrum tissue array, with stage and TNM info, 104 cases/208 cores
FDA901, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
CO951, Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores, to be replaced by CO952

Newly added tissue microarrays in recent month:

2017-06-19 EM1021a, Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases/102 cores, replacing EM1021
2017-06-19 T112c, Ovary cancer tissue array with normal tissue, including TNM and pathology grade, 12 cases/ 24 cores, replacing T112b
2017-06-12 BC12011c, Bladder cancer tissue array, including TNM, 63 cases/63 cores, replacing BC12011b
2017-06-12 GA751, Gallbladder adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/75 cores
2017-06-12 LC241h, Lung cancer tissue array with matched adjacent normal lung tissue, including TNM and pathology grade, 6 cases/24 cores, replacing LC241g
2017-06-12 T021b, Esophagus cancer tissue array with normal tissue, including TNM and pathology grade, 6 cases/24 cores, replacing T021a
2017-06-12 BL805a, Mid-advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores, replacing BL805
2017-06-12 BR1503f, Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503e
2017-06-06 FDA808i-2, Multiple organ cancer tissue array with cancer adjacent tissue as contral, including TNM, clinical stage and pathology grade, 72 cases/ 72 cores, replacing FDA808h-2
2017-06-06 BR1401, Breast cancer tissue array, including TNM and pathology grade, IHC markers Her-2 results, 140 cases/140 cores
2017-06-05 BO244f, Normal bone tissue array with osteosarcoma tissue, including TNM, 12 cases/24 cores, replacing BO244e
2017-06-05 T196b, Prostate cancer tissue array (4x (2x3) array),including TNM and pathology grade, 6 cases/24 cores, replacing T196a
2017-06-05 FDA808j, Multiple organ normal tissue array with cancer adjacent tissue as contral (2 slide set), including TNM, clinical stage and pathology grade, 72 cases/ 72 cores, replacing FDA808i
2017-05-26 LP801a, Throat malignant tumor array with cancer adjacent tissue, including TNM and pathology grade, 73 cases/80 cores, replacing LP801
2017-05-26 T053c, Colon tumor tissue array with normal colon tissue, including TNM and pathology grade, 6 cases/24 cores, replacing T053b
2017-05-26 BC081120c, Breast cancer array with adjacent normal breast tissue, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 110 cases/110 cores, replacing BC081120b
2017-05-25 HEso-Squ180Sur-03, Esophagus carcinoma tissue array, 93 cases, tumor and matched NAT with survival information.
2017-05-23 ST1401, Stomach cancer tissue array, including TNM and pathology grade, IHC markers Her-2 results, 140 cases/140 cores
2017-05-22 GA802, Extrahepatic biliary duct cancer and intrahepatic biliary duct cancer tissue array, including TNM and pathology grade, 80 cases/80 cores
2017-05-22 LC721, Lung cancer tissue array, including TNM and pathology grade, 24 cases/72 cores